Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Patanjali's Neurogrit Gold, an Ayurvedic formulation, shows promise in managing Parkinson's disease symptoms. Research published in CNS Neuroscience & ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.